Healthcare provider profile · identity verified

Jonathon Ray Long, MD

Family Practice · WEATHERFORD, OK · NPI 1477758423

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	472	119
Omeprazole	Omeprazole	320	87
Famotidine	Famotidine	312	81
Atorvastatin Calcium	Atorvastatin Calcium	287	81
Gabapentin	Gabapentin	270	77
Montelukast Sodium	Montelukast Sodium	260	78
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	228	36
Lisinopril	Lisinopril	216	60
Potassium Chloride	Potassium Chloride	196	49
Amlodipine Besylate	Amlodipine Besylate	189	55
Metformin Hcl Er	Metformin Hcl	166	50
Furosemide	Furosemide	164	36
Meloxicam	Meloxicam	152	52
Losartan Potassium	Losartan Potassium	136	38
Methylprednisolone	Methylprednisolone	136	104
Metoprolol Succinate	Metoprolol Succinate	135	36
Simvastatin	Simvastatin	135	32
Rosuvastatin Calcium	Rosuvastatin Calcium	127	38
Mounjaro	Tirzepatide	124	19
Tamsulosin Hcl	Tamsulosin Hcl	124	35
Pantoprazole Sodium	Pantoprazole Sodium	119	40
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	119	30
Albuterol Sulfate Hfa	Albuterol Sulfate	114	44
Sertraline Hcl	Sertraline Hcl	113	26
Alprazolam	Alprazolam	109	25
Buspirone Hcl	Buspirone Hcl	108	26
Ozempic	Semaglutide	107	22
Hydrochlorothiazide	Hydrochlorothiazide	103	32
Trazodone Hcl	Trazodone Hcl	101	31
Tizanidine Hcl	Tizanidine Hcl	96	35
Bupropion Xl	Bupropion Hcl	94	27
Duloxetine Hcl	Duloxetine Hcl	94	26
Eliquis	Apixaban	94	18
Celecoxib	Celecoxib	93	27
Allopurinol	Allopurinol	92	25
Morphine Sulfate Er	Morphine Sulfate	87	suppressed
Jardiance	Empagliflozin	85	13
Metformin Hcl	Metformin Hcl	81	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	23
Fluticasone Propionate	Fluticasone Propionate	77	30
Glimepiride	Glimepiride	74	23
Venlafaxine Hcl Er	Venlafaxine Hcl	73	14
Prednisone	Prednisone	72	45
Pregabalin	Pregabalin	72	16
Azithromycin	Azithromycin	71	59
Tramadol Hcl	Tramadol Hcl	70	12
Carvedilol	Carvedilol	63	15
Pravastatin Sodium	Pravastatin Sodium	63	21
Propranolol Hcl Er	Propranolol Hcl	61	17
Azelastine Hcl	Azelastine Hcl	60	28
Ropinirole Hcl	Ropinirole Hcl	59	13
Quetiapine Fumarate	Quetiapine Fumarate	57	14
Clopidogrel	Clopidogrel Bisulfate	56	16
Doxycycline Hyclate	Doxycycline Hyclate	51	41
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	11
Oxybutynin Chloride Er	Oxybutynin Chloride	49	18
Liothyronine Sodium	Liothyronine Sodium	48	15
Metoprolol Tartrate	Metoprolol Tartrate	47	12
Triamcinolone Acetonide	Triamcinolone Acetonide	47	30
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	34
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Irbesartan	Irbesartan	40	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	17
Nystatin	Nystatin	39	15
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	13
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Atenolol	Atenolol	35	suppressed
Myrbetriq	Mirabegron	34	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	20
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Lorazepam	Lorazepam	31	11
Lovastatin	Lovastatin	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Testosterone Cypionate	Testosterone Cypionate	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Fluconazole	Fluconazole	30	16
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	29	suppressed
Ondansetron Odt	Ondansetron	28	18
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Cefdinir	Cefdinir	27	24
Clonidine Hcl	Clonidine Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	11
Mirtazapine	Mirtazapine	26	suppressed
Mupirocin	Mupirocin	26	17
Estradiol	Estradiol	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Fentanyl	Fentanyl	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Temazepam	Temazepam	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	18
Clonazepam	Clonazepam	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Lubiprostone	Lubiprostone	20	suppressed
Valsartan	Valsartan	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Colestipol Hcl	Colestipol Hcl	19	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Levofloxacin	Levofloxacin	19	18
Ventolin Hfa	Albuterol Sulfate	19	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Risperidone	Risperidone	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	13
Ezetimibe	Ezetimibe	17	suppressed
Metronidazole	Metronidazole	17	15
Naproxen	Naproxen	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Modafinil	Modafinil	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Dutasteride	Dutasteride	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Finasteride	Finasteride	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Metolazone	Metolazone	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Sulfasalazine Dr	Sulfasalazine	11	suppressed
Topiramate	Topiramate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error